Article Text

Download PDFPDF
Pharmaceutical company payments to NHS trusts

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Key points

  • The Disclosure UK database includes details of payments made by the pharmaceutical industry to healthcare organisations in the UK.

  • A study analysed non-research payments made by pharmaceutical companies over a 4-year period to NHS trusts in England.

  • Over £60 million was paid by pharmaceutical companies to 234 NHS trusts between 2015 and 2018.

Analysis of data from the Disclosure UK database shows that more than 90% of NHS trusts in England received non-research-related payments from pharmaceutical companies between 2015 and 2018.1


The authors of the study used data from the Disclosure UK database ( which contains details of payments and benefits in kind made by the pharmaceutical industry to organisations and health professionals in the UK.1 Information relating to payments made during 4 years …

View Full Text


  • Contributors DTB Team.

  • Provenance and peer review Commissioned; internally peer reviewed.